Helicobacter pylori (H. pylori) infection is very common and affects approximately half of the
world population. It causes gastric diseases, but some authors have reported an association …

The extragastric manifestations of Helicobacter pylori infection still remain a very strong topic
throughout the H. pylori world. Indeed, H. pylori may interfere with many biological …

The recent pandemic of COVID-19 has made abundantly clear that Type 2 diabetes (T2D)
increases the risk of more frequent and more severe viral infections. At the same time, pro …

Background Conflicting results of recent studies on the association between Helicobacter
pylori (H. pylori) infection and the risk of insulin resistance and metabolic syndrome explored …

Background and Aim: Helicobacter pylori infection has been reported to promote the
development of a variety of extra-digestive manifestations, including type 2 diabetes …

Sickness behavior is the common denominator for a plethora of changes in normal
behavioral routines and systemic metabolism during an infection. Typical symptoms include …

Abstract α-Glucosidase and urease inhibitors have emerged as crucial for developing
therapeutic drugs targeting diabetes and gastrointestinal disorders. This study reports on …

Objective To systematically review and quantify the effect of Helicobacter pylori (H. pylori)
infection on the risk of metabolic syndrome (MS) and metabolic parameters in individuals …

Helicobacter pylori infection and diabetes mellitus are two independent common diseases. It
is showed that the worsening glycemic and metabolic control increases the rates of …

The gut microbiota is a complex ecosystem that is involved in the development and
preservation of the immune system, energy homeostasis and nutritional status of the host …